[144] UiPath, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing: A holder filed notice to sell up to 35,000 shares of common stock. The filing lists an aggregate market value of $557,550, an approximate sale date of 10/17/2025, execution through Morgan Stanley Smith Barney LLC, and NYSE as the exchange.

The shares to be sold were acquired as Restricted Stock Units on 01/01/2024 in the amount of 35,000. Shares outstanding were 453,568,899 as of the filing’s disclosure.

The filer reported recent Rule 10b5-1 sales of 10,000 shares on 10/13/2025 ($170,056), 10/14/2025 ($165,351), 10/15/2025 ($166,801), and 10/16/2025 ($163,521).

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	35000	557550.00	453568899	10/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2024	Restricted Stock Units	Issuer			35000	01/01/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/16/2025	10000	163521.00
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/15/2025	10000	166801.00
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/14/2025	10000	165351.00
10b5-1 Sales for HITESH RAMANI One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	10/13/2025	10000	170056.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PATH’s Form 144 disclose?

A planned sale of up to 35,000 shares of common stock with an aggregate market value of $557,550, to be executed via Morgan Stanley Smith Barney LLC.

When is the planned sale date for PATH shares?

The filing lists an approximate sale date of 10/17/2025.

How were the PATH shares to be sold acquired?

They were acquired as Restricted Stock Units on 01/01/2024 in the amount of 35,000 shares.

How many PATH shares are outstanding?

The filing lists 453,568,899 shares outstanding.

Which broker and exchange are named in the PATH Form 144?

Broker: Morgan Stanley Smith Barney LLC. Exchange: NYSE.

What recent 10b5-1 sales are reported for PATH shares?

Sales of 10,000 shares each on 10/13 ($170,056), 10/14 ($165,351), 10/15 ($166,801), and 10/16/2025 ($163,521).